Stock Warrants and Earnout (Tables)

12 Months Ended

Jan. 31, 2023

Equity [Abstract]

Fair Value Measurement Inputs and Valuation Techniques

The Level 3 fair value inputs used in the recurring valuation of the redeemable convertible preferred stock warrant liability were as follows:

	February 26, 2021 (Merger Date)		January 31, 2021		January 31, 2020
Expected volatility	84.3	%	80.5	%	58.4	%
Risk-free interest rate	0.0	%	0.1	%	1.6	%
Dividend rate	0.0	%	0.0	%	0.0	%
Expected term (years)	0		1.4		2.0

Schedule of Warrants

	January 31, 2023
	Outstanding Warrants			Expiration Date
	Number of Warrants	Exercise Price
Common Stock	20,922,215	$	6.03	7/31/2030 – 8/4/2030
Common Stock	13,577,221	$	9.04	11/16/2028 – 2/13/2029
Total outstanding common stock warrants	34,499,436

	January 31, 2022
	Outstanding Warrants			Expiration Date
	Number of Warrants	Exercise Price
Common Stock	21,727,177	$1.25 - $6.03		3/4/2022 - 8/6/2030
Common Stock	13,811,412	$	9.04	11/16/2028 – 2/14/2029
Total outstanding common stock warrants	35,538,589

The Private Placement Warrants were valued using the assumptions under the BLM that assumes optimal exercise of the Company’s redemption option at the earliest possible date. On February 21, 2022, the Company redeemed the remaining Private Placement Warrants for 0.355 shares of Common Stock per warrant. As of January 31, 2023, there were zero Private Placement Warrants outstanding.

	January 31, 2022			February 26, 2021 (Merger Date)
Market price of public stock	$	13.85		$	30.83
Exercise price	$	11.50		$	11.50
Expected term (years)	4.1			5.0
Volatility	70.5		%	73.5		%
Risk-free interest rate	1.0		%	0.8		%
Dividend rate	0.0		%	0.0		%